Entity Details

Primary name CPT2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP23786
EntryNameCPT2_HUMAN
FullNameCarnitine O-palmitoyltransferase 2, mitochondrial
TaxID9606
Evidenceevidence at protein level
Length658
SequenceStatuscomplete
DateCreated1991-11-01
DateModified2021-06-02

Ontological Relatives

GenesCPT2

GO terms

Show/Hide Table
GOName
GO:0001676 long-chain fatty acid metabolic process
GO:0004095 carnitine O-palmitoyltransferase activity
GO:0005654 nucleoplasm
GO:0005730 nucleolus
GO:0005739 mitochondrion
GO:0005743 mitochondrial inner membrane
GO:0006635 fatty acid beta-oxidation
GO:0006853 carnitine shuttle
GO:0008458 carnitine O-octanoyltransferase activity
GO:0009437 carnitine metabolic process
GO:0016746 acyltransferase activity
GO:0019222 regulation of metabolic process
GO:0120162 positive regulation of cold-induced thermogenesis

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion inner membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000542 Acyltransferase ChoActase/COT/CPTFamilyFamily
IPR039551 Choline/carnitine acyltransferase domainDomainDomain
IPR042231 Choline/Carnitine o-acyltransferase, domain 2FamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
600649 OMIMCarnitine palmitoyltransferase 2 deficiency, infantile (CPT2DI)An autosomal recessive disorder of mitochondrial long-chain fatty acid oxidation, characterized by hepatic or hepato-cardio-muscular manifestations with onset in infancy. Clinical features include hypoketotic hypoglycemia, lethargy, seizures, hepatomegaly, liver dysfunction, cardiomegaly and dilated cardiomyopathy. The disease is caused by variants affecting the gene represented in this entry.
608836 OMIMCarnitine palmitoyltransferase 2 deficiency, lethal neonatal (CPT2DLN)An autosomal recessive disorder of mitochondrial long-chain fatty acid oxidation with fatal outcome, presenting shortly after birth. It is characterized by respiratory distress, seizures, altered mental status, hepatomegaly, cardiomegaly, cardiac arrhythmia, and, in many cases, dysmorphic features, renal dysgenesis, and migration defects. recessive. The disease is caused by variants affecting the gene represented in this entry.
255110 OMIMCarnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D)An autosomal recessive disorder of mitochondrial long-chain fatty acid oxidation, characterized by recurrent myoglobinuria, episodes of muscle pain, stiffness, and rhabdomyolysis. These symptoms are exacerbated by prolonged exercise, fasting, cold, or viral infection. CPT2DM affects most frequently children or young adults, and severity of attacks is highly variable. Myoglobinuria can cause kidney failure and death. The disease is caused by variants affecting the gene represented in this entry.
614212 OMIMEncephalopathy, acute, infection-induced, 4 (IIAE4)A severe neurologic complication of an infection. It manifests within days in otherwise healthy children after common viral infections, without evidence of viral infection of the brain or inflammatory cell infiltration. In affected children, high-grade fever is accompanied within 12 to 48 hours by febrile convulsions, often leading to coma, multiple-organ failure, brain edema, and high morbidity and mortality. The infections are usually viral, particularly influenza, although other viruses and even mycoplasma have been found to cause the disorder. Disease susceptibility is associated with variants affecting the gene represented in this entry. CPT2 polymorphic variants do not cause classical carnitine palmitoyltransferase 2 deficiency, and patients harboring any of them are asymptomatic most of the time. However, they are prone to viral infection (high fever)-related encephalopathy (PubMed:21697855).

Drugs

Show/Hide Table
DrugNameSourceType
DB00583 LevocarnitineDrugbanksmall molecule
DB01074 PerhexilineDrugbanksmall molecule

Interactions

3 interactions